Karyopharm Therapeutics
Utility Patents
Last updated:
List of all Karyopharm Therapeutics patents 12 in total
Status | Patent |
---|---|
Grant | Utility: Nuclear transport modulators and uses thereof Filling date: 26 Sep 2025 Issue date: 21 Sep 2021 |
Grant | Utility: Polymorphs of selinexor Filling date: 26 Sep 2025 Issue date: 3 Aug 2021 |
Grant | Utility: Hydrazide containing nuclear transport modulators and uses thereof Filling date: 26 Sep 2025 Issue date: 15 Jun 2021 |
Grant | Utility: Substituted benzofuranyl and benzoxazolyl compounds and uses thereof Filling date: 26 Sep 2025 Issue date: 18 May 2021 |
Grant | Utility: Multicyclic compounds and uses thereof Filling date: 26 Sep 2025 Issue date: 8 Dec 2020 |
Grant | Utility: Nuclear transport modulators and uses thereof Filling date: 26 Sep 2025 Issue date: 14 Jul 2020 |
Grant | Utility: Hydrazide containing nuclear transport modulators and uses thereof Filling date: 26 Sep 2025 Issue date: 28 Jan 2020 |
Grant | Utility: Nuclear transport modulators and uses thereof Filling date: 26 Sep 2025 Issue date: 7 Jan 2020 |
Grant | Utility: Polymorphs of Selinexor Filling date: 26 Sep 2025 Issue date: 31 Dec 2019 |
Grant | Utility: Nuclear transport modulators and uses thereof Filling date: 26 Sep 2025 Issue date: 10 Sep 2019 |
Grant | Utility: Substituted benzofuranyl and benzoxazolyl compounds and uses thereof Filling date: 26 Sep 2025 Issue date: 3 Sep 2019 |
Grant | Utility: (S,E)-3-(6-aminopyridin-3-yl)-N-((5-(4-(3-fluoro-3-methylpyrrolidine-1-car- bonyl)phenyl-7-(4-fluorophenyl)benzofuran-2-yl)methyl)acrylamide for the treatment of cancer Filling date: 26 Sep 2025 Issue date: 30 Jul 2019 |
Showing 1 to 12 of 12 patents.